Chugai Pharmaceutical Co., Ltd. provided earnings guidance for the full year ending December 31, 2021. On consolidated basis, the company expects revenues of ¥168,817 million, core operating profit of ¥65,353 million, core net income of ¥48,396 million and core earnings per share of ¥29.42.